-
Mashup Score: 1Current Issue | ASH Clinical News | American Society of Hematology - 3 month(s) ago
Current Issue | ASH Clinical News | American Society of Hematology Current Issue October 2024 Election 2024: Health Care Issues on the Ballot The outcome of this year’s presidential election will have far-reaching ramifications for several issues that affect hematologists and their patients, from maternal health to affordable health insurance. Viewpoints Editor’s Corner Appreciating “All Kinds of Minds” in Hematology:…
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0FDA Approves Chronic GVHD Treatment | ASH Clinical News | American Society of Hematology - 3 month(s) ago
Axatilimab-csfr received approval from the U.S. Food and Drug Administration (FDA) to treat chronic graft-versus-host disease (GVHD) in adult and pediatric (who weigh at least 88.2 pounds) patients who have received at least two prior lines of therapy. The treatment is an anti-CSF-1R antibody. Approval was granted based on the results of the global AGAVE-201 study, which demonstrated a 75% overall response rate within the first six months of treatment. The median time to response was 1.5 months, and 60%
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet-
Having demonstrated a 75% ORR within the first six months of treatment, #axatilimab was granted #FDA approval to treat chronic #GVHD in patients who have received at least two prior lines of therapy: https://t.co/iR9eyZVynz
-
-
Mashup Score: 2Population-Based Data Shows No Association Between Autoimmune Disease, MGUS | ASH Clinical News | American Society of Hematology - 3 month(s) ago
Leah Lawrence is a freelance health writer and editor based in Delaware. There was no association between autoimmune diseases and monoclonal gammopathy of undetermined significance (MGUS) in a large systematically screened population, according to a study published in Annals of Internal Medicine. 1 Based on this finding, “routine screening for MGUS among individuals with autoimmune disease is not recommended,” said study researcher Ingigerdur Sverrisdottir, MD, of University of Iceland in Reykjavik and
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet-
Patients with #autoimmune #diseases have not been found to have an increased risk of #monoclonal #gammopathy of undetermined significance, according to findings from a large systematically screened #Icelandic population: https://t.co/4u3qHggFT3
-
-
Mashup Score: 1Call for ASH Clinical News Associate Editors (2025-2027) | ASH Clinical News | American Society of Hematology - 3 month(s) ago
The American Society of Hematology (ASH) is in search of an Associate Editor to join ASH Clinical News, the Society’s monthly news magazine for the broader hematology/oncology community. The position term is three years and runs from January 1, 2025, through December 31, 2027. As an Associate Editor, you’ll have the opportunity to share your views on topics in the field by writing one to two Editor’s Corner columns per year, participating in brainstorming sessions to develop ideas for feature stories and
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Want to be part of the ASH Clinical News team? Apply today to be an associate editor! 🩸 For more information, visit: https://t.co/PU6YVYwIjP. There is an immediate need for an editor who specializes in #lymphomas, but all areas of expertise in #hematology are welcome. https://t.co/atQgA8Jjna
-
-
Mashup Score: 1ASH Clinical News: October 2024 From the Desk Of... - 3 month(s) ago
Editor-in-Chief Aaron Gerds, MD, previews the upcoming October issue of ASH Clinical News. Highlights of this issue include a look into the critical health c…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
See what's to come next month! The October issue takes an in-depth look at some of the #healthcare topics at stake in the 2024 #election, along with articles on #menin inhibitors in #AML, #vemurafenib and #obinutuzumab for #HairyCellLeukemia, and more. https://t.co/40y5drgdr7
-
-
Mashup Score: 1HCT Shows Better Outcomes in Young Pediatric Patients With Fanconi Anemia | ASH Clinical News | American Society of Hematology - 3 month(s) ago
Lara C. Pullen, PhD, is a freelance medical writer in Chicago, Illinois. Data from the largest series of pediatric patients with Fanconi anemia (FA) to date suggest that hematopoietic cell transplantation (HCT) should be offered at a young age in patients with aplastic anemia (AA) or bone marrow failure (BMF). The new study confirms excellent survival after matched family or unrelated donor HCT and improved survival after haploidentical (HID) HCT using either ex vivo T-cell depletion or post-transplant
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
Data from the largest series of #pediatric patients with #Fanconi #anemia to date suggest that #HCT should be offered at a young age, with excellent survival after matched family or unrelated donor HCT and improved survival after haploidentical HCT: https://t.co/HXHjuRN7s4
-
-
Mashup Score: 0Fully Automated Lugano Response Assessment Achieves High Accuracy in FDG-Avid Non-Hodgkin Lymphoma | ASH Clinical News | American Society of Hematology - 3 month(s) ago
Katie Robinson is a medical writer based in New York. A deep learning-based method for fully automated Lugano treatment response assessment in 1 8 F-fluorodeoxyglucose (FDG)–avid non-Hodgkin lymphoma (NHL) performed similarly to medical experts on FDG–PET. This is according to a study published in the Journal of Clinical Oncology. “Current response assessments can be time-consuming and can hinder the adoption of more labor-intensive disease burden metrics in response assessments (e.g., TMTV [total
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
A deep learning-based #algorithm for fully automated Lugano treatment response assessment in FDG–avid #nonHodgkin #lymphoma was found to perform similarly to medical experts on FDG–PET, achieving high agreement with the adjudicated #radiologic responses: https://t.co/2d9pcvY7X0
-
-
Mashup Score: 1Cognitive Dysfunction Can Lurk After Remission of Complement-Mediated Thrombotic Microangiopathy | ASH Clinical News | American Society of Hematology - 4 month(s) ago
Lara C. Pullen, PhD, is a freelance medical writer in Chicago, Illinois. In adults, complement clears excess neurotransmitters and old proteins from the brain and helps to regulate neurogenesis. Now, new findings indicate that patients with previous complement-mediated thrombotic microangiopathy (CM-TMA) have impaired memory and concentration as well as significant, albeit nonspecific, cerebral white matter abnormalities. Pauline Kosalka, MD, a resident at Western University in Canada, and colleagues
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
New research using #MRI indicates that patients with previous complement-mediated #ThromboticMicroangiopathy have impaired memory and concentration and cerebral white matter abnormalities, which can persist for months to years after achieving remission: https://t.co/ZDR9DhZk6P
-
-
Mashup Score: 1Call for ASH Clinical News Associate Editors (2025-2027) | ASH Clinical News | American Society of Hematology - 4 month(s) ago
The American Society of Hematology (ASH) is in search of an Associate Editor to join ASH Clinical News, the Society’s monthly news magazine for the broader hematology/oncology community. The position term is three years and runs from January 1, 2025, through December 31, 2027. As an Associate Editor, you’ll have the opportunity to share your views on topics in the field by writing one to two Editor’s Corner columns per year, participating in brainstorming sessions to develop ideas for feature stories and
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
Want to be part of the ASH Clinical News team? Apply today to be an associate editor! 🩸 For more information, visit: https://t.co/BOjJRkMVSG. There is an immediate need for an editor who specializes in #lymphomas, but all areas of expertise in #hematology are welcome. https://t.co/16keOvIaSA
-
-
Mashup Score: 1
Ana Casanegra, MD, MS Associate Professor of Medicine Director, Thrombosis, Anticoagulation and Thrombophilia Clinic Mayo Clinic Rochester, MN Tanna Tan, MBBCh Resident, Internal Medicine Mayo Clinic Rochester, MN A physically active 70-year-old male patient presented with left-sided facial droop and limb weakness. MR venography revealed venous sinus thrombosis involving the left sigmoid sinus and the left internal jugular bulb. Of note, he had been initiated on implantable testosterone replacement eight
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Follow the link to view the full clinical dilemma and see how the experts responded: https://t.co/zNqcQvhx6b
-
The October issue is out now! 🩸Check out the full lineup, including a feature on the critical #healthcare issues in the upcoming #presidential #election and a discussion on #menin inhibitors in #AML, on our website: https://t.co/Eva8bBW1EV https://t.co/XSty6Xf8nU